» Articles » PMID: 23571666

Understanding Neurological Disease Mechanisms in the Era of Epigenetics

Overview
Journal JAMA Neurol
Date 2013 Apr 11
PMID 23571666
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The burgeoning field of epigenetics is making a significant impact on our understanding of brain evolution, development, and function. In fact, it is now clear that epigenetic mechanisms promote seminal neurobiological processes, ranging from neural stem cell maintenance and differentiation to learning and memory. At the molecular level, epigenetic mechanisms regulate the structure and activity of the genome in response to intracellular and environmental cues, including the deployment of cell type-specific gene networks and those underlying synaptic plasticity. Pharmacological and genetic manipulation of epigenetic factors can, in turn, induce remarkable changes in neural cell identity and cognitive and behavioral phenotypes. Not surprisingly, it is also becoming apparent that epigenetics is intimately involved in neurological disease pathogenesis. Herein, we highlight emerging paradigms for linking epigenetic machinery and processes with neurological disease states, including how (1) mutations in genes encoding epigenetic factors cause disease, (2) genetic variation in genes encoding epigenetic factors modify disease risk, (3) abnormalities in epigenetic factor expression, localization, or function are involved in disease pathophysiology, (4) epigenetic mechanisms regulate disease-associated genomic loci, gene products, and cellular pathways, and (5) differential epigenetic profiles are present in patient-derived central and peripheral tissues.

Citing Articles

Integrating epigenetic modification and stem cell therapy strategies: A novel approach for advancing Alzheimer's disease treatment - A literature review.

Widaja E, Pawitan J Narra J. 2025; 4(3):e935.

PMID: 39816083 PMC: 11731673. DOI: 10.52225/narra.v4i3.202.


Integrative multi-omics and systems bioinformatics in translational neuroscience: A data mining perspective.

OConnor L, OConnor B, Lim S, Zeng J, Lo C J Pharm Anal. 2023; 13(8):836-850.

PMID: 37719197 PMC: 10499660. DOI: 10.1016/j.jpha.2023.06.011.


Exploring the Genetic Predisposition to Epigenetic Changes in Alzheimer's Disease.

Bryzgalov L, Korbolina E, Merkulova T Int J Mol Sci. 2023; 24(9).

PMID: 37175659 PMC: 10177989. DOI: 10.3390/ijms24097955.


Assessment of aberrant DNA methylation two years after paediatric critical illness: a pre-planned secondary analysis of the international PEPaNIC trial.

Coppens G, Vanhorebeek I, Verlinden I, Derese I, Wouters P, Joosten K Epigenetics. 2022; 18(1):2146966.

PMID: 36384393 PMC: 9980627. DOI: 10.1080/15592294.2022.2146966.


Spatial and temporal dynamics of HDACs class IIa following mild traumatic brain injury in adult rats.

Kamal S, Potukutchi S, Gelovani D, Bonomi R, Kallakuri S, Cavanaugh J Mol Psychiatry. 2022; 27(3):1683-1693.

PMID: 35027678 PMC: 11629393. DOI: 10.1038/s41380-021-01369-7.


References
1.
Shimojo M . Huntingtin regulates RE1-silencing transcription factor/neuron-restrictive silencer factor (REST/NRSF) nuclear trafficking indirectly through a complex with REST/NRSF-interacting LIM domain protein (RILP) and dynactin p150 Glued. J Biol Chem. 2008; 283(50):34880-6. PMC: 2596380. DOI: 10.1074/jbc.M804183200. View

2.
Pasmant E, Sabbagh A, Vidaud M, Bieche I . ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J. 2010; 25(2):444-8. DOI: 10.1096/fj.10-172452. View

3.
Uchida H, Ma L, Ueda H . Epigenetic gene silencing underlies C-fiber dysfunctions in neuropathic pain. J Neurosci. 2010; 30(13):4806-14. PMC: 6632306. DOI: 10.1523/JNEUROSCI.5541-09.2010. View

4.
van Bokhoven H . Genetic and epigenetic networks in intellectual disabilities. Annu Rev Genet. 2011; 45:81-104. DOI: 10.1146/annurev-genet-110410-132512. View

5.
Qureshi I, Mehler M . Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease. Nat Rev Neurosci. 2012; 13(8):528-41. PMC: 3478095. DOI: 10.1038/nrn3234. View